Rankings
▼
Calendar
IMA (ImageneBio Inc) Stock Financials & Earnings | Market Cap Arena
IMA
ImageneBio Inc
Mkt Cap
$67M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$45M
EPS (TTM)
-$3.44
Free Cash Flow (TTM)
-$47M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
-100.0%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$5M
-$10M
-$15M
Q1 23
$5M
$5M
-$16M
Q2 23
$2M
-$12M
-$18M
Q3 23
$1M
$943K
-$20M
Q4 23
$659K
$354K
-$22M
Q1 24
$0
-$10M
-$18M
Q2 24
$0
-$400K
-$16M
Q3 24
$0
-$7M
-$12M
Q4 24
$0
-$5M
-$13M
Q1 25
$0
-$4M
-$11M
Q2 25
$0
-$45K
-$9M
Q3 25
$0
$0
-$27M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
4.3x
—
Q1 23
3.8x
—
Q2 23
3.5x
—
Q3 23
4.8x
—
Q4 23
7.3x
—
Q1 24
17.5x
—
Q2 24
36.5x
—
Q3 24
102.1x
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$18M
-$18M
Q1 23
-$20M
-$20M
Q2 23
-$18M
-$18M
Q3 23
-$20M
-$20M
Q4 23
-$22M
-$22M
Q1 24
-$18M
-$18M
Q2 24
-$13M
-$13M
Q3 24
-$9M
-$9M
Q4 24
-$6M
-$6M
Q1 25
-$11M
-$11M
Q2 25
-$3M
-$3M
Q3 25
-$27M
-$27M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$231K
Q1 23
$152K
Q2 23
$0
Q3 23
$0
Q4 23
$262K
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-73.0%
+18.0%
Q1 23
+57.0%
+2.4%
Q2 23
+424.6%
-3.9%
Q3 23
-81.5%
-14.8%
Q4 23
-87.9%
+9.7%
Q1 24
-100.0%
-12.5%
Q2 24
-100.0%
-22.8%
Q3 24
-100.0%
-40.0%
Q4 24
-100.0%
-44.5%
Q1 25
—
-40.8%
Q2 25
—
-44.7%
Q3 25
—
+114.3%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$0
0.0%
Q1 23
$2M
37.6%
Q2 23
$0
0.0%
Q3 23
$2M
168.6%
Q4 23
$2M
266.3%
Q1 24
$2M
—
Q2 24
$1M
—
Q3 24
$1M
—
Q4 24
$998K
—
Q1 25
$904K
—
Q2 25
$458K
—
Q3 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$16M
$5M
Q1 23
$16M
$5M
Q2 23
$15M
$5M
Q3 23
$1M
$6M
Q4 23
$14M
$8M
Q1 24
$10M
$6M
Q2 24
$10M
$5M
Q3 24
$7M
$5M
Q4 24
$5M
$8M
Q1 25
$4M
$6M
Q2 25
$4M
$4M
Q3 25
$16M
$11M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$60M
$97M
$157M
Q1 23
$29M
$108M
$138M
Q2 23
$71M
$86M
$157M
Q3 23
$121M
$76M
$197M
Q4 23
$120M
$56M
$175M
Q1 24
$53M
$104M
$157M
Q2 24
$44M
$101M
$145M
Q3 24
$45M
$93M
$138M
Q4 24
$39M
$85M
$124M
Q1 25
$37M
$77M
$114M
Q2 25
$58M
$37M
$96M
Q3 25
$103M
$39M
$143M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
36M
+0.0%
Q1 23
36M
+0.0%
Q2 23
43M
+19.8%
Q3 23
43M
+0.0%
Q4 23
48M
+10.1%
Q1 24
48M
+0.9%
Q2 24
48M
+0.0%
Q3 24
48M
+0.0%
Q4 24
48M
+0.0%
Q1 25
48M
+0.0%
Q2 25
48M
+0.0%
Q3 25
9M
-82.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
$462K
67
FY 22
$195K
80
FY 23
$213K
43
FY 24
$350K
10
marketcaparena.com